Hypoxanthine phosphoribosyltransferase (HPRT, atmosphere of 5% C02/95% air. Methods for growing cells on plastic petri plates and for the selection of HPRT-deficient mutants or revertants have been previously described (12) . When large quantities of cells are desired, they are grown in suspension at a density of S to 100 X 104/ml in Joklik's modified minimal essential medium (Gibco, 13.3 g of powder medium per liter) containing 5% calf serum (Irvine Scientific).
by nonmutationally induced stable phenotypic changes, HPRT deficiency is correlated in many cases with an alteration in the enzyme protein. Putative somatic cell mutants produce HPRT enzyme with altered temperature sensitivity, altered Km for a substrate, altered isoelectric pH, or antigenicity without enzyme activity (8) (9) (10) (11) (12) . Additional proof of a structural gene mutation would be the identification of an altered tryptic peptide in the mutant protein and the determination of the amino acid substitution.
We previously described HeLa mutant H23 (12) , which lacks HPRT activity but synthesizes normal amounts of HPRT crossreacting material. The mutant HPRT protein focuses at a more acidic pH on isoelectric focusing gels. In this paper we describe micro methods that enable us to identify an altered tryptic peptide in the mutant H23 HPRT protein.
MATERIALS AND METHODS
Cell Growth Conditions. HeLa cells are grown at 370 in an atmosphere of 5% C02/95% air. Methods for growing cells on plastic petri plates and for the selection of HPRT-deficient mutants or revertants have been previously described (12) . When large quantities of cells are desired, they are grown in suspension at a density of S to 100 X 104/ml in Joklik's modified minimal essential medium (Gibco, 13 .3 g of powder medium per liter) containing 5% calf serum (Irvine Scientific).
Radioisotope-labeled amino acids are incorporated into HeLa proteins as previously described (12) with minor modifications.
A modified formulation of Dulbecco's modified Eagle's medium (DME) (13) lacks an amino acid (methionine, lysine, or arginine) and contains 10% calf serum, 22 mM sodium bicarbonate, and 15 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (Hepes) buffer adjusted to pH 7 Trypsin treatment is conducted at room temperature (about 230). To the lyophilized sample, 50,ul of 1% ammonium bicarbonate, pH 8.1, and 2 ,l of a 1 ,ug/,ul solution of trypsin (Worthington TRTPCK, 217 units/mg) are added, and the mixture is allowed to stand for 4 hr. An additional 50,l of ammonium bicarbonate buffer and 3 jul of trypsin are added, and the mixture is allowed to stand for an additional 16-20 hr.
The trypsinized sample is lyophilized to remove the ammonium bicarbonate, and redissolved in water.
Aminex A-5 Column Chromatography of HPRT Tryptic Peptides. A 2 X 150 mm glass microbore jacketed column (Altex) is filled with 0.4 ml of Aminex A-5 (Bio-Rad). During column packing and peptide separation, the column is maintained at 50°. At the end of each peptide separation the column is recycled by washing with successive 5-10 ml volumes of 1 M NaOH; 0.1 M pyridine acetate at pH 3.0 (0.1 M pyridine adjusted with acetic acid to pH 3.0); 3 M pyridine acetate at pH 5.5. The column is then washed extensively (about 15 ml) with 0.1 M pyridine acetate, pH 3.0, until the conductivity reaches 5.5 mho (1 mho = 1 siemens, S). The same column has been used for more than 25 peptide separations.
Before application to the column, a sample of tryptic peptides in water is. adjusted to 5% (vol/vol) formic acid with concentrated formic acid. The sample (2-20 Mg containing 5-20,000 cpm in 20-200A1) is applied to the column under 45 pounds/ inch2 (310 kPa) from a pressurized nitrogen cylinder. All additional fluid is applied by a Milton Roy minipump operating at a flow rate of 6-9 ml/hr and a pressure of 200-400 pounds/ inch2 (1.4-2.8 MPa). After sample application, approximately 1.7 ml of 0.1 M pyridine acetate (pH 3.0) is passed through the column. Next, a gradient of ionic strength and pH is applied by pumping the effluent from an equal-level two-chamber linear gradient apparatus containing 10 ml of 0.1 M pyridine acetate (pH 3.0) in the mixing chamber and 10 ml of 1.2 M pyridine acetate (pH 5.0) in the other chamber. At the end of the gradient the column is washed with 1.7 ml of 1.2 M pyridine acetate (pH 5.0), 1.7 ml of 2 M Tris-HC1 (pH 8.0), and 7.0 ml of 1 M NaOH. The column is then recycled as described above. A conductivity meter (Lab Data Control) with a flow cell of 10 Ml is used to monitor the conductivity of the fractions.
Four-drop fractions (0.17 ml) are collected directly into 7 ml plastic mini-scintillation vials placed in test tube racks of an LKB fraction collector. Five milliliters of scintillation fluid and 0.5 ml of water are added to each fraction and the radioactivity is determined by counting for 5 or 10 min in a Packard Tri-Carb liquid scintillation counter with a counting efficiency of 22-26% for 3H and 47-56% for 35S. RESULTS HPRT from cell extracts can be purified 5 to 10,000-fold by a simple three-step procedure consisting of high-speed centrifugation, adsorption to Sepharose-conjugated HPRT antibody, and NaDodSO4/polyacrylamide gel electrophoresis. The purification of HPRT is equally successful with radioisotopelabeled extract (Fig. 1 ) and unlabeled extract (Fig. 2) . The following evidence demonstrates that the purified protein on NaDodSO4/polyacrylamide gels is HPRT: The NaDodSO4/ polyacrylamide gel fraction migrates as if it has a molecular weight of 25-26,000, which we have previously shown is the subunit molecular weight for human HPRT (15) . Very little radioactivity or protein occurs in other areas of the gel. When 125I-labeled HPRT (16) is mixed with crude HeLa extract, the iodinated enzyme is located with the purified protein peak on the NaDodSO4 gel. Neither the iodinated enzyme nor the cellular HPRT protein peak appears in the NaDodSO4 gel if Sepharose-conjugated preimmune antibody (12) is substituted for the Sepharose-conjugated HPRT antibody. Also, no protein peak is observed for HeLa mutants lacking HPRT crossreacting material.
The amount of radioactivity at each step of a sample purification is listed in Table 1 . Approximately 0.01% of the radioisotope-labeled amino acid in a crude extract is recovered in the HPRT NaDodSO4 polyacrylamide gel fraction. In control experiments, 50% of iodinated HPRT added to a crude extract is recovered in this fraction. Therefore, we conclude that HPRT comprises 0.02% of the radioisotope-labeled protein. This value is the same as the weight percentage of HPRT calculated by dividing the specific activity of the enzyme in cell extracts, 4 milliunits/mg, by the specific activity of the purified enzyme, 17.5 units/mg (17) .
HPRT is separated from NaDodSO4 by precipitating the protein with 20% trichloroacetic acid in the presence of 100 Mg/ml bovine serum albumin. This procedure precipitates 80-90% of the labeled HPRT, and experiments with [-6S] NaDodSO4 indicate that at least 98% of the NaDodSO4 is removed. The trichloroacetic acid is extracted with HCI, and the Biochemistry: Milman et Final HPRT purification step: NaDodSO4/polyacrylamide gel electrophoresis. Radioisotope-labeled HPRT was purified by the three-step procedure described in Materials and Methods. The figure displays the data for the final purification step. The amounts of lysine-, arginine-, and methionine-labeled protein applied to each gel were 3.6 X 105, 1 1% sodium deoxycholate, and 1 M NaCl. The column was allowed to warm to room temperature, and was then washed with 10 ml of room-temperature water. The enzyme was eluted with 0.2% NaDodSO4 and 0.4 ml fractions were collected. NaDodSO4/polyacrylamide gel electrophoresis of 30 ,l samples of fractions of 1-5 was performed in vertical slab gels as previously described (15 (Fig. 3A) . Peaks 1 and 2 are eluted in the initial application buffer; peaks 3 to 9 are eluted by the pyridine acetate gradient; and a broad peak 10 is eluted by the sodium hydroxide wash. The positions of [3H]lysine-labeled tryptic peptide peaks in the chromatography pattern of the H23 mutant HPRT (Fig.  3B ) are identical to that in the wild-type pattern except that a new peak labeled "X" appears in the pattern. In addition to the new peak X, the mutant displays a relative increase in the size of peak 3 and a corresponding decrease in the relative size of peak 10 .
The chromatography patterns of wild-type and H23 mutant HPRT [3H]arginine tryptic peptides (Fig. 3C, and D and H23 mutant HPRT. Radioisotope-labeled HPRT was prepared as described in Materials and Methods. The amounts of lysine-, arginine-, and methionine-labeled HPRT applied to the Aminex column were 5810, 7950, and 11,800 cpm for wild-type protein and 14,000, 6570, and 5400 cpm for H23 protein, respectively. All fractions were counted for 10 min, except the wild-type methionine fractions, which were counted for 5 Fig. 3 are listed along with the ratio to peak 9 for lysine peptides, ratio to peak 3 for arginine peptides, and ratio to the average cpm for methionine peptides-1300 for wildtype, 671 for H23 HPRT. Assuming one labeled amino acid in lysine peak 9 and arginine peak 3, the sum of the ratios indicates the total number of lysines and arginines per protein.
interpretation of one-dimensional tryptic peptide patterns.
Trypsin cleaves on the COOH-terminal side of lysine and arginine residues. Thus, each tryptic peptide should contain only one lysine or one arginine except for the COOH-terminal tryptic peptide which contains neither lysine nor arginine unless the amino acid is the COOH-terminal residue of the protein.
By labeling with only one of these amino acids, we can independently observe the chromatography pattern of either the lysine or arginine peptides. Each peptide should contain the same amount of radioactivity, but multiple peptides with similar ionic properties can and do occur at the same location in the elution pattern (Fig. 3) , producing peaks of different areas.
The relative areas under the peaks in the lysine or arginine elution profiles indicate the corresponding number of lysine or arginine peptides in the peaks. Integral values should be obtained for the number of peptides in the peak. In general, the data in Table 2 indicate that integral values are obtained when lysine peak 9 is incorporated, only those tryptic peptides containing that amino acid appear in the pattern. Sometimes these peaks can be correlated with lysine or arginine peptides. For example, in Fig. 2 methionine peak 3 appears to be identical to lysine peak 5. Potentially, an extension of this type of analysis could be used to determine the number and type of amino acid residues in the tryptic peptides.
Methionine peak 2 occurs at a location where there are no lysine-or arginine-labeled peptides, indicating that this peak is the COOH-terminal tryptic peptide of the protein. This finding is significant because the COOH-terminal peptide should always be altered in chain-termination (amber or ochre) or frameshift mutations. Moreover, it may be possible to identify the COOH-terminal cyanogen bromide cleavage product (cleaved at methionine residues) as a trypsin-resistant fragment.
An interesting feature of the tryptic peptide patterns is that they may be used to determine the total number of residues of the labeled amino acid in the protein. Conventional amino acid analysis of erythrocyte HPRT indicates that the protein contains 12 arginine, 5 to 6 methionine, and 16 lysine residues (17) . The data in Table 2 suggest that both wild-type and H23 mutant HeLa HPRT contain 11 arginine and 4 methionine residues. Both the erythrocyte and HeLa wild-type enzymes appear to contain 16 lysine residues, but the H23 mutant HPRT protein may contain an extra lysine residue. Although only one representative experiment is shown in Table 2 , consistent results have been obtained in repeated experiments. The appearance in the H23 mutant HPRT protein of a new lysine-labeled peptide provides strong evidence for a mutation in the HPRT structural gene.
